{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:12:31Z","timestamp":1781712751271,"version":"3.54.5"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T00:00:00Z","timestamp":1680739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T00:00:00Z","timestamp":1680739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS118066"],"award-info":[{"award-number":["R01NS118066"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Blazer Foundation"},{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Biallelic mutations in<jats:italic>CYP27A1<\/jats:italic>and<jats:italic>CYP7B1<\/jats:italic>, two critical genes regulating cholesterol and bile acid metabolism, cause cerebrotendinous xanthomatosis (CTX) and hereditary spastic paraplegia type 5 (SPG5), respectively. These rare diseases are characterized by progressive degeneration of corticospinal motor neuron axons, yet the underlying pathogenic mechanisms and strategies to mitigate axonal degeneration remain elusive.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>To generate induced pluripotent stem cell (iPSC)-based models for CTX and SPG5, we reprogrammed patient skin fibroblasts into iPSCs by transducing fibroblast cells with episomal vectors containing pluripotency factors. These patient-specific iPSCs, as well as control iPSCs, were differentiated into cortical projection neurons (PNs) and examined for biochemical alterations and disease-related phenotypes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>CTX and SPG5 patient iPSC-derived cortical PNs recapitulated several disease-specific biochemical changes and axonal defects of both diseases. Notably, the bile acid chenodeoxycholic acid (CDCA) effectively mitigated the biochemical alterations and rescued axonal degeneration in patient iPSC-derived neurons. To further examine underlying disease mechanisms, we developed CYP7B1 knockout human embryonic stem cell (hESC) lines using CRISPR-cas9-mediated gene editing and, following differentiation, examined hESC-derived cortical PNs. Knockout of CYP7B1 resulted in similar axonal vesiculation and degeneration in human cortical PN axons, confirming a cause-effect relationship between gene deficiency and axonal degeneration. Interestingly, CYP7B1 deficiency led to impaired neurofilament expression and organization as well as axonal degeneration, which could be rescued with CDCA, establishing a new disease mechanism and therapeutic target to mitigate axonal degeneration.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our data demonstrate disease-specific lipid disturbances and axonopathy mechanisms in human pluripotent stem cell-based neuronal models of CTX and SPG5 and identify CDCA, an established treatment of CTX, as a potential pharmacotherapy for SPG5. We propose this novel treatment strategy to rescue axonal degeneration in SPG5, a currently incurable condition.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13023-023-02666-w","type":"journal-article","created":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T13:04:42Z","timestamp":1680786282000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Chenodeoxycholic acid rescues axonal degeneration in induced pluripotent stem cell-derived neurons from spastic paraplegia type 5 and cerebrotendinous xanthomatosis patients"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9548-4674","authenticated-orcid":false,"given":"Yongchao","family":"Mou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7170-8709","authenticated-orcid":false,"given":"Ghata","family":"Nandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhada","family":"Mukte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorgen E.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troels T.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Criscuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Blackstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Fraidakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1899-9134","authenticated-orcid":false,"given":"Xue-Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,6]]},"reference":[{"issue":"8","key":"2666_CR1","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/hipo.20548","volume":"19","author":"L Fester","year":"2009","unstructured":"Fester L, Zhou L, Butow A, Huber C, von Lossow R, Prange-Kiel J, et al. Cholesterol-promoted synaptogenesis requires the conversion of cholesterol to estradiol in the hippocampus. Hippocampus. 2009;19(8):692\u2013705.","journal-title":"Hippocampus"},{"issue":"2","key":"2666_CR2","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.mcn.2005.02.006","volume":"29","author":"C Goritz","year":"2005","unstructured":"Goritz C, Mauch DH, Pfrieger FW. Multiple mechanisms mediate cholesterol-induced synaptogenesis in a CNS neuron. Mol Cell Neurosci. 2005;29(2):190\u2013201.","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"2666_CR3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1194\/jlr.P071639","volume":"58","author":"J Abdel-Khalik","year":"2017","unstructured":"Abdel-Khalik J, Yutuc E, Crick PJ, Gustafsson JA, Warner M, Roman G, et al. Defective cholesterol metabolism in amyotrophic lateral sclerosis. J Lipid Res. 2017;58(1):267\u201378.","journal-title":"J Lipid Res"},{"issue":"9","key":"2666_CR4","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1194\/jlr.R006338","volume":"51","author":"I Bjorkhem","year":"2010","unstructured":"Bjorkhem I, Leoni V, Meaney S. Genetic connections between neurological disorders and cholesterol metabolism. J Lipid Res. 2010;51(9):2489\u2013503.","journal-title":"J Lipid Res"},{"issue":"2","key":"2666_CR5","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.ajhg.2007.10.001","volume":"82","author":"MK Tsaousidou","year":"2008","unstructured":"Tsaousidou MK, Ouahchi K, Warner TT, Yang Y, Simpson MA, Laing NG, et al. Sequence alterations within CYP7B1 implicate defective cholesterol homeostasis in motor-neuron degeneration. Am J Hum Genet. 2008;82(2):510\u20135.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"2666_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nrn2946","volume":"12","author":"C Blackstone","year":"2011","unstructured":"Blackstone C, O\u2019Kane CJ, Reid E. Hereditary spastic paraplegias: membrane traffic and the motor pathway. Nat Rev Neurosci. 2011;12(1):31\u201342.","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"2666_CR7","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/WCO.0000000000000585","volume":"31","author":"L Parodi","year":"2018","unstructured":"Parodi L, Coarelli G, Stevanin G, Brice A, Durr A. Hereditary ataxias and paraparesias: clinical and genetic update. Curr Opin Neurol. 2018;31(4):462\u201371.","journal-title":"Curr Opin Neurol"},{"key":"2666_CR8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.conb.2018.04.025","volume":"51","author":"C Blackstone","year":"2018","unstructured":"Blackstone C. Converging cellular themes for the hereditary spastic paraplegias. Curr Opin Neurobiol. 2018;51:139\u201346.","journal-title":"Curr Opin Neurobiol"},{"issue":"4","key":"2666_CR9","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1194\/jlr.M002543","volume":"51","author":"R Schule","year":"2010","unstructured":"Schule R, Siddique T, Deng HX, Yang Y, Donkervoort S, Hansson M, et al. Marked accumulation of 27-hydroxycholesterol in SPG5 patients with hereditary spastic paresis. J Lipid Res. 2010;51(4):819\u201323.","journal-title":"J Lipid Res"},{"issue":"1","key":"2666_CR10","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1093\/cercor\/bhy274","volume":"29","author":"P Merino-Serrais","year":"2019","unstructured":"Merino-Serrais P, Loera-Valencia R, Rodriguez-Rodriguez P, Parrado-Fernandez C, Ismail MA, Maioli S, et al. 27-hydroxycholesterol induces aberrant morphology and synaptic dysfunction in hippocampal neurons. Cereb Cortex. 2019;29(1):429\u201346.","journal-title":"Cereb Cortex"},{"issue":"7","key":"2666_CR11","doi-asserted-by":"publisher","first-page":"11855","DOI":"10.18632\/oncotarget.14416","volume":"8","author":"SM Kim","year":"2017","unstructured":"Kim SM, Noh MY, Kim H, Cheon SY, Lee KM, Lee J, et al. 25-Hydroxycholesterol is involved in the pathogenesis of amyotrophic lateral sclerosis. Oncotarget. 2017;8(7):11855\u201367.","journal-title":"Oncotarget"},{"issue":"3","key":"2666_CR12","first-page":"238","volume":"78","author":"Y Wang","year":"2019","unstructured":"Wang Y, An Y, Zhang D, Yu H, Zhang X, Tao L, et al. 27-Hydroxycholesterol alters synaptic structural and functional plasticity in hippocampal neuronal cultures. J Neuropathol Exp Neurol. 2019;78(3):238\u201347.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"12","key":"2666_CR13","doi-asserted-by":"publisher","first-page":"7779","DOI":"10.1016\/S0021-9258(20)89518-0","volume":"266","author":"JJ Cali","year":"1991","unstructured":"Cali JJ, Hsieh CL, Francke U, Russell DW. Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J Biol Chem. 1991;266(12):7779\u201383.","journal-title":"J Biol Chem"},{"issue":"6","key":"2666_CR14","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s10545-017-0093-8","volume":"40","author":"G Salen","year":"2017","unstructured":"Salen G, Steiner RD. Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX). J Inherit Metab Dis. 2017;40(6):771\u201381.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"2666_CR15","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.jacl.2018.06.008","volume":"12","author":"PB Duell","year":"2018","unstructured":"Duell PB, Salen G, Eichler FS, DeBarber AE, Connor SL, Casaday L, et al. Diagnosis, treatment, and clinical outcomes in 43 cases with cerebrotendinous xanthomatosis. J Clin Lipidol. 2018;12(5):1169\u201378.","journal-title":"J Clin Lipidol"},{"issue":"2","key":"2666_CR16","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1172\/JCI112030","volume":"76","author":"G Salen","year":"1985","unstructured":"Salen G, Shefer S, Tint GS, Nicolau G, Dayal B, Batta AK. Biosynthesis of bile acids in cerebrotendinous xanthomatosis Relationship of bile acid pool sizes and synthesis rates to hydroxylations at C-12, C-25, and C-26. J Clin Investig. 1985;76(2):744\u201351.","journal-title":"J Clin Investig"},{"issue":"4","key":"2666_CR17","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/brain\/awz382","volume":"143","author":"OJ Rickman","year":"2020","unstructured":"Rickman OJ, Baple EL, Crosby AH. Lipid metabolic pathways converge in motor neuron degenerative diseases. Brain. 2020;143(4):1073\u201387.","journal-title":"Brain"},{"issue":"5","key":"2666_CR18","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861\u201372.","journal-title":"Cell"},{"issue":"5858","key":"2666_CR19","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"J Yu","year":"2007","unstructured":"Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318(5858):1917\u201320.","journal-title":"Science"},{"issue":"5","key":"2666_CR20","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.stem.2016.10.015","volume":"19","author":"Y Tao","year":"2016","unstructured":"Tao Y, Zhang SC. Neural subtype specification from human pluripotent stem cells. Cell Stem Cell. 2016;19(5):573\u201386.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"2666_CR21","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/ane.12188","volume":"129","author":"P Roos","year":"2014","unstructured":"Roos P, Svenstrup K, Danielsen ER, Thomsen C, Nielsen JE. CYP7B1: novel mutations and magnetic resonance spectroscopy abnormalities in hereditary spastic paraplegia type 5A. Acta Neurol Scand. 2014;129(5):330\u20134.","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"2666_CR22","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nmeth.1591","volume":"8","author":"K Okita","year":"2011","unstructured":"Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S, et al. A more efficient method to generate integration-free human iPS cells. Nat Methods. 2011;8(5):409\u201312.","journal-title":"Nat Methods"},{"issue":"1","key":"2666_CR23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1242\/dmm.021766","volume":"9","author":"CC Xu","year":"2016","unstructured":"Xu CC, Denton KR, Wang ZB, Zhang X, Li XJ. Abnormal mitochondrial transport and morphology as early pathological changes in human models of spinal muscular atrophy. Dis Model Mech. 2016;9(1):39\u201349.","journal-title":"Dis Model Mech"},{"key":"2666_CR24","first-page":"e50321","volume":"74","author":"EM Boisvert","year":"2013","unstructured":"Boisvert EM, Denton K, Lei L, Li XJ. The specification of telencephalic glutamatergic neurons from human pluripotent stem cells. J Vis Exp. 2013;74:e50321.","journal-title":"J Vis Exp"},{"issue":"23","key":"2666_CR25","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1242\/dev.036624","volume":"136","author":"XJ Li","year":"2009","unstructured":"Li XJ, Zhang X, Johnson MA, Wang ZB, Lavaute T, Zhang SC. Coordination of sonic hedgehog and Wnt signaling determines ventral and dorsal telencephalic neuron types from human embryonic stem cells. Development. 2009;136(23):4055\u201363.","journal-title":"Development"},{"issue":"21","key":"2666_CR26","doi-asserted-by":"publisher","first-page":"5638","DOI":"10.1093\/hmg\/ddu280","volume":"23","author":"PP Zhu","year":"2014","unstructured":"Zhu PP, Denton KR, Pierson TM, Li XJ, Blackstone C. Pharmacologic rescue of axon growth defects in a human iPSC model of hereditary spastic paraplegia SPG3A. Hum Mol Genet. 2014;23(21):5638\u201348.","journal-title":"Hum Mol Genet"},{"issue":"7","key":"2666_CR27","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9(7):671\u20135.","journal-title":"Nat Methods"},{"issue":"14","key":"2666_CR28","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1093\/hmg\/ddy156","volume":"27","author":"K Denton","year":"2018","unstructured":"Denton K, Mou Y, Xu CC, Shah D, Chang J, Blackstone C, et al. Impaired mitochondrial dynamics underlie axonal defects in hereditary spastic paraplegias. Hum Mol Genet. 2018;27(14):2517\u201330.","journal-title":"Hum Mol Genet"},{"issue":"9","key":"2666_CR29","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.jpain.2013.03.005","volume":"14","author":"HT Cheng","year":"2013","unstructured":"Cheng HT, Dauch JR, Porzio MT, Yanik BM, Hsieh W, Smith AG, et al. Increased axonal regeneration and swellings in intraepidermal nerve fibers characterize painful phenotypes of diabetic neuropathy. J Pain. 2013;14(9):941\u20137.","journal-title":"J Pain"},{"issue":"5","key":"2666_CR30","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1212\/01.WNL.0000070781.92512.A4","volume":"61","author":"G Lauria","year":"2003","unstructured":"Lauria G, Morbin M, Lombardi R, Borgna M, Mazzoleni G, Sghirlanzoni A, et al. Axonal swellings predict the degeneration of epidermal nerve fibers in painful neuropathies. Neurology. 2003;61(5):631\u20136.","journal-title":"Neurology"},{"issue":"3","key":"2666_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/BF00688117","volume":"64","author":"PH Pop","year":"1984","unstructured":"Pop PH, Joosten E, van Spreeken A, Gabreels-Festen A, Jaspar H, ter Laak H, et al. Neuroaxonal pathology of central and peripheral nervous systems in cerebrotendinous xanthomatosis (CTX). Acta Neuropathol. 1984;64(3):259\u201364.","journal-title":"Acta Neuropathol"},{"issue":"1\u20133","key":"2666_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0022-510X(87)90009-8","volume":"82","author":"V Voiculescu","year":"1987","unstructured":"Voiculescu V, Alexianu M, Popescu-Tismana G, Pastia M, Petrovici A, Dan A. Polyneuropathy with lipid deposits in Schwann cells and axonal degeneration in cerebrotendinous xanthomatosis. J Neurol Sci. 1987;82(1\u20133):89\u201399.","journal-title":"J Neurol Sci"},{"issue":"11","key":"2666_CR33","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1093\/hmg\/ddab367","volume":"31","author":"E Piermarini","year":"2022","unstructured":"Piermarini E, Akarsu S, Connors T, Kneussel M, Lane MA, Morfini G, et al. Modeling gain-of-function and loss-of-function components of SPAST-based hereditary spastic paraplegia using transgenic mice. Hum Mol Genet. 2022;31(11):1844\u201359.","journal-title":"Hum Mol Genet"},{"issue":"16","key":"2666_CR34","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1093\/hmg\/ddac063","volume":"31","author":"L Marrone","year":"2022","unstructured":"Marrone L, Marchi PM, Webster CP, Marroccella R, Coldicott I, Reynolds S, et al. SPG15 protein deficits are at the crossroads between lysosomal abnormalities, altered lipid metabolism and synaptic dysfunction. Hum Mol Genet. 2022;31(16):2693\u2013710.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"2666_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007363","volume":"14","author":"R De Pace","year":"2018","unstructured":"De Pace R, Skirzewski M, Damme M, Mattera R, Mercurio J, Foster AM, et al. Altered distribution of ATG9A and accumulation of axonal aggregates in neurons from a mouse model of AP-4 deficiency syndrome. PLoS Genet. 2018;14(4): e1007363.","journal-title":"PLoS Genet"},{"issue":"1","key":"2666_CR36","first-page":"72","volume":"6","author":"C Fassier","year":"2013","unstructured":"Fassier C, Tarrade A, Peris L, Courageot S, Mailly P, Dalard C, et al. Microtubule-targeting drugs rescue axonal swellings in cortical neurons from spastin knockout mice. Dis Model Mech. 2013;6(1):72\u201383.","journal-title":"Dis Model Mech"},{"key":"2666_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.clineuro.2013.12.008","volume":"118","author":"E Luyckx","year":"2014","unstructured":"Luyckx E, Eyskens F, Simons A, Beckx K, Van West D, Dhar M. Long-term follow-up on the effect of combined therapy of bile acids and statins in the treatment of cerebrotendinous xanthomatosis: a case report. Clin Neurol Neurosurg. 2014;118:9\u201311.","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"2666_CR38","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0026-0495(99)90040-9","volume":"48","author":"A Verrips","year":"1999","unstructured":"Verrips A, Wevers RA, Van Engelen BG, Keyser A, Wolthers BG, Barkhof F, et al. Effect of simvastatin in addition to chenodeoxycholic acid in patients with cerebrotendinous xanthomatosis. Metabolism. 1999;48(2):233\u20138.","journal-title":"Metabolism"},{"issue":"1","key":"2666_CR39","doi-asserted-by":"publisher","first-page":"9615","DOI":"10.1038\/s41598-019-45246-4","volume":"9","author":"K Rehbach","year":"2019","unstructured":"Rehbach K, Kesavan J, Hauser S, Ritzenhofen S, Jungverdorben J, Schule R, et al. Multiparametric rapid screening of neuronal process pathology for drug target identification in HSP patient-specific neurons. Sci Rep. 2019;9(1):9615.","journal-title":"Sci Rep"},{"issue":"12","key":"2666_CR40","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1093\/brain\/awx273","volume":"140","author":"L Schols","year":"2017","unstructured":"Schols L, Rattay TW, Martus P, Meisner C, Baets J, Fischer I, et al. Hereditary spastic paraplegia type 5: natural history, biomarkers and a randomized controlled trial. Brain. 2017;140(12):3112\u201327.","journal-title":"Brain"},{"issue":"Pt 6","key":"2666_CR41","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1093\/brain\/awp073","volume":"132","author":"C Goizet","year":"2009","unstructured":"Goizet C, Boukhris A, Durr A, Beetz C, Truchetto J, Tesson C, et al. CYP7B1 mutations in pure and complex forms of hereditary spastic paraplegia type 5. Brain. 2009;132(Pt 6):1589\u2013600.","journal-title":"Brain"},{"issue":"2","key":"2666_CR42","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.apsb.2014.12.009","volume":"5","author":"E Kwong","year":"2015","unstructured":"Kwong E, Li Y, Hylemon PB, Zhou H. Bile acids and sphingosine-1-phosphate receptor 2 in hepatic lipid metabolism. Acta Pharm Sin B. 2015;5(2):151\u20137.","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"2666_CR43","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/stem.1569","volume":"32","author":"KR Denton","year":"2014","unstructured":"Denton KR, Lei L, Grenier J, Rodionov V, Blackstone C, Li XJ. Loss of spastin function results in disease-specific axonal defects in human pluripotent stem cell-based models of hereditary spastic paraplegia. Stem Cells. 2014;32(2):414\u201323.","journal-title":"Stem Cells"},{"issue":"5","key":"2666_CR44","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s10545-014-9695-6","volume":"37","author":"D Dai","year":"2014","unstructured":"Dai D, Mills PB, Footitt E, Gissen P, McClean P, Stahlschmidt J, et al. Liver disease in infancy caused by oxysterol 7 alpha-hydroxylase deficiency: successful treatment with chenodeoxycholic acid. J Inherit Metab Dis. 2014;37(5):851\u201361.","journal-title":"J Inherit Metab Dis"},{"key":"2666_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2013.76","volume":"3","author":"MJ Fraidakis","year":"2013","unstructured":"Fraidakis MJ. Psychiatric manifestations in cerebrotendinous xanthomatosis. Transl Psychiatry. 2013;3: e302.","journal-title":"Transl Psychiatry"},{"issue":"4","key":"2666_CR46","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1017\/S1092852900000067","volume":"15","author":"O Bonnot","year":"2010","unstructured":"Bonnot O, Fraidakis MJ, Lucanto R, Chauvin D, Kelley N, Plaza M, et al. Cerebrotendinous xanthomatosis presenting with severe externalized disorder: improvement after one year of treatment with chenodeoxycholic Acid. CNS Spectr. 2010;15(4):231\u20136.","journal-title":"CNS Spectr"},{"issue":"12","key":"2666_CR47","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1194\/jlr.R075630","volume":"58","author":"TY Chang","year":"2017","unstructured":"Chang TY, Yamauchi Y, Hasan MT, Chang C. Cellular cholesterol homeostasis and Alzheimer\u2019s disease. J Lipid Res. 2017;58(12):2239\u201354.","journal-title":"J Lipid Res"},{"issue":"20","key":"2666_CR48","doi-asserted-by":"publisher","first-page":"10130","DOI":"10.1073\/pnas.1821306116","volume":"116","author":"RR Voskuhl","year":"2019","unstructured":"Voskuhl RR, Itoh N, Tassoni A, Matsukawa MA, Ren E, Tse V, et al. Gene expression in oligodendrocytes during remyelination reveals cholesterol homeostasis as a therapeutic target in multiple sclerosis. P Natl Acad Sci USA. 2019;116(20):10130\u20139.","journal-title":"P Natl Acad Sci USA"},{"issue":"3","key":"2666_CR49","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1084\/jem.20160534","volume":"214","author":"MA Ismail","year":"2017","unstructured":"Ismail MA, Mateos L, Maioli S, Merino-Serrais P, Ali Z, Lodeiro M, et al. 27-Hydroxycholesterol impairs neuronal glucose uptake through an IRAP\/GLUT4 system dysregulation. J Exp Med. 2017;214(3):699\u2013717.","journal-title":"J Exp Med"},{"issue":"4","key":"2666_CR50","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/MOL.0b013e328362df13","volume":"24","author":"I Bjorkhem","year":"2013","unstructured":"Bjorkhem I. Cerebrotendinous xanthomatosis. Curr Opin Lipidol. 2013;24(4):283\u20137.","journal-title":"Curr Opin Lipidol"},{"issue":"4","key":"2666_CR51","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1006\/mgme.2000.3106","volume":"71","author":"KS Bramlett","year":"2000","unstructured":"Bramlett KS, Yao S, Burris TP. Correlation of farnesoid X receptor coactivator recruitment and cholesterol 7alpha-hydroxylase gene repression by bile acids. Mol Genet Metab. 2000;71(4):609\u201315.","journal-title":"Mol Genet Metab"},{"issue":"4","key":"2666_CR52","first-page":"595","volume":"86","author":"M Kallner","year":"1975","unstructured":"Kallner M. The effect of chenodeoxycholic acid feeding on bile acid kinetics and fecal neutral steroid excretion in patients with hyperlipoproteinemia types II and IV. J Lab Clin Med. 1975;86(4):595\u2013604.","journal-title":"J Lab Clin Med"},{"issue":"1","key":"2666_CR53","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1093\/brain\/awx297","volume":"141","author":"C Marelli","year":"2018","unstructured":"Marelli C, Lamari F, Rainteau D, Lafourcade A, Banneau G, Humbert L, et al. Plasma oxysterols: biomarkers for diagnosis and treatment in spastic paraplegia type 5. Brain. 2018;141(1):72\u201384.","journal-title":"Brain"},{"issue":"26","key":"2666_CR54","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1056\/NEJM198412273112601","volume":"311","author":"VM Berginer","year":"1984","unstructured":"Berginer VM, Salen G, Shefer S. Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. N Engl J Med. 1984;311(26):1649\u201352.","journal-title":"N Engl J Med"},{"issue":"11","key":"2666_CR55","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1093\/brain\/awab488","volume":"145","author":"Z Chen","year":"2022","unstructured":"Chen Z, Chai E, Mou Y, Roda RH, Blackstone C, Li XJ. Inhibiting mitochondrial fission rescues degeneration in hereditary spastic paraplegia neurons. Brain. 2022;145(11):4016\u201331.","journal-title":"Brain"},{"key":"2666_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2021.610857","volume":"14","author":"C Gu","year":"2021","unstructured":"Gu C. Rapid and reversible development of axonal varicosities: a new form of neural plasticity. Front Mol Neurosci. 2021;14: 610857.","journal-title":"Front Mol Neurosci"},{"issue":"11","key":"2666_CR57","doi-asserted-by":"publisher","first-page":"4829","DOI":"10.1172\/JCI68506","volume":"124","author":"S Theofilopoulos","year":"2014","unstructured":"Theofilopoulos S, Griffiths WJ, Crick PJ, Yang S, Meljon A, Ogundare M, et al. Cholestenoic acids regulate motor neuron survival via liver X receptors. J Clin Investig. 2014;124(11):4829\u201342.","journal-title":"J Clin Investig"},{"issue":"3","key":"2666_CR58","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/BF00427359","volume":"378","author":"S Yagishita","year":"1978","unstructured":"Yagishita S. Morphological investigations on axonal swellings and spheroids in various human diseases. Virchows Arch A Pathol Anat Histol. 1978;378(3):181\u201397.","journal-title":"Virchows Arch A Pathol Anat Histol"},{"issue":"1","key":"2666_CR59","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1038\/s41467-021-24390-4","volume":"12","author":"D Lang-Ouellette","year":"2021","unstructured":"Lang-Ouellette D, Gruver KM, Smith-Dijak A, Blot FGC, Stewart CA, de VanssaydeBlavous P, et al. Purkinje cell axonal swellings enhance action potential fidelity and cerebellar function. Nat Commun. 2021;12(1):4129.","journal-title":"Nat Commun"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02666-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-023-02666-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02666-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T21:07:01Z","timestamp":1729199221000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-023-02666-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,6]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2666"],"URL":"https:\/\/doi.org\/10.1186\/s13023-023-02666-w","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,6]]},"assertion":[{"value":"18 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments involving hESCs and iPSCs were approved by the University of Illinois Institutional Biosafety Committee and Embryonic Stem Cell Research Oversight Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing financial interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}